Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.

Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, Tardon A, Wu X, Schabath MB, Teare MD, Le Marchand L, Zhang ZF, Field JK, Brenner H, Diao N, Xie J, Kohno T, Harris CC, Wenzlaff AS, Fernandez-Tardon G, Ye Y, Taylor F, Wilkens LR, Davies M, Liu Y, Barnett MJ, Goodman GE, Morgenstern H, Holleczek B, Brown MC, Liu G, Hung RJ.

J Thorac Oncol. 2019 Sep;14(9):1594-1607. doi: 10.1016/j.jtho.2019.05.031. Epub 2019 Jun 1.

PMID:
31163278
2.

Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT.

Uthoff J, Stephens MJ, Newell JD Jr, Hoffman EA, Larson J, Koehn N, De Stefano FA, Lusk CM, Wenzlaff AS, Watza D, Neslund-Dudas C, Carr LL, Lynch DA, Schwartz AG, Sieren JC.

Med Phys. 2019 Jul;46(7):3207-3216. doi: 10.1002/mp.13592. Epub 2019 Jun 7.

PMID:
31087332
3.

Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients.

Lusk CM, Watza D, Dyson G, Craig D, Ratliff V, Wenzlaff AS, Lonardo F, Bollig-Fischer A, Bepler G, Purrington K, Gadgeel S, Schwartz AG.

Clin Cancer Res. 2019 Jul 15;25(14):4300-4308. doi: 10.1158/1078-0432.CCR-18-2439. Epub 2019 Apr 12.

PMID:
30979741
4.

Circulating Inflammation Proteins Associated With Lung Cancer in African Americans.

Meaney CL, Mitchell KA, Zingone A, Brown D, Bowman E, Yu Y, Wenzlaff AS, Neslund-Dudas C, Pine SR, Cao L, Schwartz AG, Ryan BM.

J Thorac Oncol. 2019 Jul;14(7):1192-1203. doi: 10.1016/j.jtho.2019.03.014. Epub 2019 Apr 3.

PMID:
30953795
5.

Quantitative Imaging Markers of Lung Function in a Smoking Population Distinguish COPD Subgroups with Differential Lung Cancer Risk.

Lusk CM, Wenzlaff AS, Watza D, Sieren JC, Robinette N, Walworth G, Petrich M, Neslund-Dudas C, Flynn MJ, Song T, Spizarny D, Simoff MJ, Soubani AO, Gadgeel S, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):724-730. doi: 10.1158/1055-9965.EPI-18-0886. Epub 2019 Jan 14.

PMID:
30642838
6.

Prognostic modeling of the immune-centric transcriptome reveals interleukin signaling candidates contributing to differential patient outcomes.

Watza D, Lusk CM, Dyson G, Purrington KS, Chen K, Wenzlaff AS, Ratliff V, Neslund-Dudas C, Bepler G, Schwartz AG.

Carcinogenesis. 2018 Dec 31;39(12):1447-1454. doi: 10.1093/carcin/bgy119.

PMID:
30202894
7.

Genome-wide association study of familial lung cancer.

Byun J, Schwartz AG, Lusk C, Wenzlaff AS, de Andrade M, Mandal D, Gaba C, Yang P, You M, Kupert EY, Anderson MW, Han Y, Li Y, Qian D, Stilp A, Laurie C, Nelson S, Zheng W, Hung RJ, Gaborieau V, Mckay J, Brennan P, Caporaso NE, Landi MT, Wu X, McLaughlin JR, Brhane Y, Bossé Y, Pinney SM, Bailey-Wilson JE, Amos CI.

Carcinogenesis. 2018 Sep 21;39(9):1135-1140. doi: 10.1093/carcin/bgy080.

8.

Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry.

Jones CC, Mercaldo SF, Blume JD, Wenzlaff AS, Schwartz AG, Chen H, Deppen SA, Bush WS, Crawford DC, Chanock SJ, Blot WJ, Grogan EL, Aldrich MC.

J Thorac Oncol. 2018 Oct;13(10):1464-1473. doi: 10.1016/j.jtho.2018.05.032. Epub 2018 Jun 6.

9.

Germline Genetic Variants and Lung Cancer Survival in African Americans.

Jones CC, Bush WS, Crawford DC, Wenzlaff AS, Schwartz AG, Wiencke JK, Wrensch MR, Blot WJ, Chanock SJ, Grogan EL, Aldrich MC.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1288-1295. doi: 10.1158/1055-9965.EPI-16-0998. Epub 2017 Jun 15.

10.

Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study.

Fehringer G, Brenner DR, Zhang ZF, Lee YA, Matsuo K, Ito H, Lan Q, Vineis P, Johansson M, Overvad K, Riboli E, Trichopoulou A, Sacerdote C, Stucker I, Boffetta P, Brennan P, Christiani DC, Hong YC, Landi MT, Morgenstern H, Schwartz AG, Wenzlaff AS, Rennert G, McLaughlin JR, Harris CC, Olivo-Marston S, Orlow I, Park BJ, Zauderer M, Barros Dios JM, Ruano Raviña A, Siemiatycki J, Koushik A, Lazarus P, Fernández-Somoano A, Tardon A, Le Marchand L, Brenner H, Saum KU, Duell EJ, Andrew AS, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Holcatova I, Pesatori AC, Consonni D, Olsson A, Straif K, Hung RJ.

Int J Cancer. 2017 May 1;140(9):1976-1984. doi: 10.1002/ijc.30618. Epub 2017 Feb 27.

11.

Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Zanetti KA, Wang Z, Aldrich M, Amos CI, Blot WJ, Bowman ED, Burdette L, Cai Q, Caporaso N, Chung CC, Gillanders EM, Haiman CA, Hansen HM, Henderson BE, Kolonel LN, Marchand LL, Li S, McNeill LH, Ryan BM, Schwartz AG, Sison JD, Spitz MR, Tucker M, Wenzlaff AS, Wiencke JK, Wilkens L, Wrensch MR, Wu X, Zheng W, Zhou W, Christiani D, Palmer JR, Penning TM, Rieber AG, Rosenberg L, Ruiz-Narvaez EA, Su L, Vachani A, Wei Y, Whitehead AS, Chanock SJ, Harris CC.

Lung Cancer. 2016 Aug;98:33-42. doi: 10.1016/j.lungcan.2016.05.008. Epub 2016 May 13.

12.

Risk of Lung Cancer Associated with COPD Phenotype Based on Quantitative Image Analysis.

Schwartz AG, Lusk CM, Wenzlaff AS, Watza D, Pandolfi S, Mantha L, Cote ML, Soubani AO, Walworth G, Wozniak A, Neslund-Dudas C, Ardisana AA, Flynn MJ, Song T, Spizarny DL, Kvale PA, Chapman RA, Gadgeel SM.

Cancer Epidemiol Biomarkers Prev. 2016 Sep;25(9):1341-7. doi: 10.1158/1055-9965.EPI-16-0176. Epub 2016 Jul 6.

13.

Gene by Environment Investigation of Incident Lung Cancer Risk in African-Americans.

David SP, Wang A, Kapphahn K, Hedlin H, Desai M, Henderson M, Yang L, Walsh KM, Schwartz AG, Wiencke JK, Spitz MR, Wenzlaff AS, Wrensch MR, Eaton CB, Furberg H, Mark Brown W, Goldstein BA, Assimes T, Tang H, Kooperberg CL, Quesenberry CP, Tindle H, Patel MI, Amos CI, Bergen AW, Swan GE, Stefanick ML.

EBioMedicine. 2016 Jan 11;4:153-61. doi: 10.1016/j.ebiom.2016.01.002. eCollection 2016 Feb.

14.

Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysema.

Lusk CM, Wenzlaff AS, Dyson G, Purrington KS, Watza D, Land S, Soubani AO, Gadgeel SM, Schwartz AG.

Carcinogenesis. 2016 Feb;37(2):139-144. doi: 10.1093/carcin/bgv248. Epub 2015 Dec 30.

15.

Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.

Pine SR, Mechanic LE, Enewold L, Bowman ED, Ryan BM, Cote ML, Wenzlaff AS, Loffredo CA, Olivo-Marston S, Chaturvedi A, Caporaso NE, Schwartz AG, Harris CC.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):488-97. doi: 10.1158/1055-9965.EPI-15-0378. Epub 2015 Dec 28.

16.

Racial diversity of actionable mutations in non-small cell lung cancer.

Bollig-Fischer A, Chen W, Gadgeel SM, Wenzlaff AS, Cote ML, Schwartz AG, Bepler G.

J Thorac Oncol. 2015 Feb;10(2):250-5. doi: 10.1097/JTO.0000000000000420.

17.

A DRD1 polymorphism predisposes to lung cancer among those exposed to secondhand smoke during childhood.

Robles AI, Yang P, Jen J, McClary AC, Calhoun K, Bowman ED, Vähäkangas K, Greathouse KL, Wang Y, Olivo-Marston S, Wenzlaff AS, Deng B, Schwartz AG, Ryan BM.

Cancer Prev Res (Phila). 2014 Dec;7(12):1210-8. doi: 10.1158/1940-6207.CAPR-14-0158. Epub 2014 Oct 3.

18.

Re-contacting participants for inclusion in the database of Genotypes and Phenotypes (dbGaP): Findings from three case-control studies of lung cancer.

Cote ML, Harrison MJ, Wenzlaff AS, Schwartz AG.

Genome Med. 2014 Jul 23;6(7):54. doi: 10.1186/s13073-014-0054-x. eCollection 2014.

19.

Apoptosis-Related Single Nucleotide Polymorphisms and the Risk of Non-Small Cell Lung Cancer in Women.

Pathak A, Wenzlaff AS, Hyland PL, Cote ML, Keele GR, Land S, Boulton ML, Schwartz AG.

J Cancer Ther Res. 2014;3(1). doi: 10.7243/2049-7962-3-1.

20.

Survival in women with NSCLC: the role of reproductive history and hormone use.

Katcoff H, Wenzlaff AS, Schwartz AG.

J Thorac Oncol. 2014 Mar;9(3):355-61. doi: 10.1097/JTO.0000000000000077.

21.

Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO).

Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, Brenner H, Müller H, Harris CC, Duell EJ, Andrew AS, McLaughlin JR, Schwartz AG, Wenzlaff AS, Stucker I.

Br J Cancer. 2013 Oct 1;109(7):1954-64. doi: 10.1038/bjc.2013.506. Epub 2013 Sep 3.

22.

Role of selected genetic variants in lung cancer risk in African Americans.

Spitz MR, Amos CI, Land S, Wu X, Dong Q, Wenzlaff AS, Schwartz AG.

J Thorac Oncol. 2013 Apr;8(4):391-7. doi: 10.1097/JTO.0b013e318283da29.

23.

Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans.

Walsh KM, Amos CI, Wenzlaff AS, Gorlov IP, Sison JD, Wu X, Spitz MR, Hansen HM, Lu EY, Wei C, Zhang H, Chen W, Lloyd SM, Frazier ML, Bracci PM, Seldin MF, Wrensch MR, Schwartz AG, Wiencke JK.

Oncotarget. 2012 Nov;3(11):1428-38.

24.

Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans.

Walsh KM, Gorlov IP, Hansen HM, Wu X, Spitz MR, Zhang H, Lu EY, Wenzlaff AS, Sison JD, Wei C, Lloyd SM, Chen W, Frazier ML, Seldin MF, Bierut LJ, Bracci PM, Wrensch MR, Schwartz AG, Wiencke JK, Amos CI.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):251-60. doi: 10.1158/1055-9965.EPI-12-1007-T. Epub 2012 Dec 5.

25.

Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.

Hartz SM, Short SE, Saccone NL, Culverhouse R, Chen L, Schwantes-An TH, Coon H, Han Y, Stephens SH, Sun J, Chen X, Ducci F, Dueker N, Franceschini N, Frank J, Geller F, Gubjartsson D, Hansel NN, Jiang C, Keskitalo-Vuokko K, Liu Z, Lyytikäinen LP, Michel M, Rawal R, Rosenberger A, Scheet P, Shaffer JR, Teumer A, Thompson JR, Vink JM, Vogelzangs N, Wenzlaff AS, Wheeler W, Xiao X, Yang BZ, Aggen SH, Balmforth AJ, Baumeister SE, Beaty T, Bennett S, Bergen AW, Boyd HA, Broms U, Campbell H, Chatterjee N, Chen J, Cheng YC, Cichon S, Couper D, Cucca F, Dick DM, Foroud T, Furberg H, Giegling I, Gu F, Hall AS, Hällfors J, Han S, Hartmann AM, Hayward C, Heikkilä K, Hewitt JK, Hottenga JJ, Jensen MK, Jousilahti P, Kaakinen M, Kittner SJ, Konte B, Korhonen T, Landi MT, Laatikainen T, Leppert M, Levy SM, Mathias RA, McNeil DW, Medland SE, Montgomery GW, Muley T, Murray T, Nauck M, North K, Pergadia M, Polasek O, Ramos EM, Ripatti S, Risch A, Ruczinski I, Rudan I, Salomaa V, Schlessinger D, Styrkársdóttir U, Terracciano A, Uda M, Willemsen G, Wu X, Abecasis G, Barnes K, Bickeböller H, Boerwinkle E, Boomsma DI, Caporaso N, Duan J, Edenberg HJ, Francks C, Gejman PV, Gelernter J, Grabe HJ, Hops H, Jarvelin MR, Viikari J, Kähönen M, Kendler KS, Lehtimäki T, Levinson DF, Marazita ML, Marchini J, Melbye M, Mitchell BD, Murray JC, Nöthen MM, Penninx BW, Raitakari O, Rietschel M, Rujescu D, Samani NJ, Sanders AR, Schwartz AG, Shete S, Shi J, Spitz M, Stefansson K, Swan GE, Thorgeirsson T, Völzke H, Wei Q, Wichmann HE, Amos CI, Breslau N, Cannon DS, Ehringer M, Grucza R, Hatsukami D, Heath A, Johnson EO, Kaprio J, Madden P, Martin NG, Stevens VL, Stitzel JA, Weiss RB, Kraft P, Bierut LJ.

Arch Gen Psychiatry. 2012 Aug;69(8):854-60. doi: 10.1001/archgenpsychiatry.2012.124.

26.

Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25.

Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, Han Y, Huang H, Jin G, Kohno T, Ma JZ, Przybeck TR, Sanders AR, Smith JA, Sung YJ, Wenzlaff AS, Wu C, Yoon D, Chen YT, Cheng YC, Cho YS, David SP, Duan J, Eaton CB, Furberg H, Goate AM, Gu D, Hansen HM, Hartz S, Hu Z, Kim YJ, Kittner SJ, Levinson DF, Mosley TH, Payne TJ, Rao DC, Rice JP, Rice TK, Schwantes-An TH, Shete SS, Shi J, Spitz MR, Sun YV, Tsai FJ, Wang JC, Wrensch MR, Xian H, Gejman PV, He J, Hunt SC, Kardia SL, Li MD, Lin D, Mitchell BD, Park T, Schwartz AG, Shen H, Wiencke JK, Wu JY, Yokota J, Amos CI, Bierut LJ.

Genet Epidemiol. 2012 May;36(4):340-51. doi: 10.1002/gepi.21627. Erratum in: Genet Epidemiol. 2012 Jul;36(5):525-6.

27.

The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.

Mina N, Soubani AO, Cote ML, Suwan T, Wenzlaff AS, Jhajhria S, Samarah H, Schwartz AG.

Clin Lung Cancer. 2012 Mar;13(2):149-56. doi: 10.1016/j.cllc.2011.09.006. Epub 2011 Nov 29.

28.

Admixture mapping of lung cancer in 1812 African-Americans.

Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM, McKeigue PM.

Carcinogenesis. 2011 Mar;32(3):312-7. doi: 10.1093/carcin/bgq252. Epub 2010 Nov 29.

29.

Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X, Cichon S, Giegling I, Han S, Han Y, Keskitalo-Vuokko K, Kong X, Landi MT, Ma JZ, Short SE, Stephens SH, Stevens VL, Sun L, Wang Y, Wenzlaff AS, Aggen SH, Breslau N, Broderick P, Chatterjee N, Chen J, Heath AC, Heliövaara M, Hoft NR, Hunter DJ, Jensen MK, Martin NG, Montgomery GW, Niu T, Payne TJ, Peltonen L, Pergadia ML, Rice JP, Sherva R, Spitz MR, Sun J, Wang JC, Weiss RB, Wheeler W, Witt SH, Yang BZ, Caporaso NE, Ehringer MA, Eisen T, Gapstur SM, Gelernter J, Houlston R, Kaprio J, Kendler KS, Kraft P, Leppert MF, Li MD, Madden PA, Nöthen MM, Pillai S, Rietschel M, Rujescu D, Schwartz A, Amos CI, Bierut LJ.

PLoS Genet. 2010 Aug 5;6(8). pii: e1001053. doi: 10.1371/journal.pgen.1001053.

30.

Racial differences in the association between SNPs on 15q25.1, smoking behavior, and risk of non-small cell lung cancer.

Schwartz AG, Cote ML, Wenzlaff AS, Land S, Amos CI.

J Thorac Oncol. 2009 Oct;4(10):1195-201. doi: 10.1097/JTO.0b013e3181b244ef.

31.

Results from a prostate cancer admixture mapping study in African-American men.

Bock CH, Schwartz AG, Ruterbusch JJ, Levin AM, Neslund-Dudas C, Land SJ, Wenzlaff AS, Reich D, McKeigue P, Chen W, Heath EI, Powell IJ, Kittles RA, Rybicki BA.

Hum Genet. 2009 Nov;126(5):637-42. doi: 10.1007/s00439-009-0712-z. Epub 2009 Jul 1.

32.

Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.

Van Dyke AL, Cote ML, Wenzlaff AS, Chen W, Abrams J, Land S, Giroux CN, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1829-40. doi: 10.1158/1055-9965.EPI-08-0962.

33.

Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies.

Van Dyke AL, Cote ML, Wenzlaff AS, Land S, Schwartz AG.

Cytokine. 2009 May;46(2):236-44. doi: 10.1016/j.cyto.2009.02.003. Epub 2009 Apr 7. Erratum in: Cytokine. 2010 Feb;49(2):235.

34.

Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review.

Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, Butkiewicz D, Fong KM, Gené M, Hirvonen A, Kiyohara C, Larsen JE, Lin P, Raaschou-Nielsen O, Povey AC, Reszka E, Risch A, Schneider J, Schwartz AG, Sorensen M, To-Figueras J, Tokudome S, Pu Y, Yang P, Wenzlaff AS, Wikman H, Taioli E.

Am J Epidemiol. 2009 Apr 1;169(7):802-14. doi: 10.1093/aje/kwn417. Epub 2009 Feb 24.

35.

Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.

Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani AO.

J Thorac Oncol. 2009 Mar;4(3):291-9. doi: 10.1097/JTO.0b013e3181951cd1.

36.

Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women.

Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, Van Dyke AL, Land SJ, Schwartz AG.

Carcinogenesis. 2009 Apr;30(4):626-35. doi: 10.1093/carcin/bgp033. Epub 2009 Jan 27.

37.

Development and validation of a lung cancer risk prediction model for African-Americans.

Etzel CJ, Kachroo S, Liu M, D'Amelio A, Dong Q, Cote ML, Wenzlaff AS, Hong WK, Greisinger AJ, Schwartz AG, Spitz MR.

Cancer Prev Res (Phila). 2008 Sep;1(4):255-65. doi: 10.1158/1940-6207.CAPR-08-0082.

38.

Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.

Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P, Schwartz AG.

J Cancer Epidemiol. 2009;2009:242151. doi: 10.1155/2009/242151. Epub 2010 Feb 18.

39.

COX-2/EGFR expression and survival among women with adenocarcinoma of the lung.

Van Dyke AL, Cote ML, Prysak GM, Claeys GB, Wenzlaff AS, Murphy VC, Lonardo F, Schwartz AG.

Carcinogenesis. 2008 Sep;29(9):1781-7. doi: 10.1093/carcin/bgn107. Epub 2008 May 2.

40.

Regular adult aspirin use decreases the risk of non-small cell lung cancer among women.

Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):148-57. doi: 10.1158/1055-9965.EPI-07-0517. Epub 2008 Jan 9.

41.

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.

Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, Skafar DF, Lonardo F.

J Clin Oncol. 2007 Dec 20;25(36):5785-92.

PMID:
18089876
42.

Racial differences in cancer risk among relatives of patients with early onset lung cancer.

Naff JL, Coté ML, Wenzlaff AS, Schwartz AG.

Chest. 2007 May;131(5):1289-94. Epub 2007 Mar 30.

PMID:
17400658
43.

Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.

Cote ML, Wenzlaff AS, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Lung Cancer. 2007 Mar;55(3):255-62. Epub 2006 Dec 15.

44.

Secondary cancers after a lung carcinoid primary: a population-based analysis.

Cote ML, Wenzlaff AS, Philip PA, Schwartz AG.

Lung Cancer. 2006 Jun;52(3):273-9. Epub 2006 Mar 29.

PMID:
16567020
45.

CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR, Schwartz AG.

Carcinogenesis. 2005 Dec;26(12):2207-12. Epub 2005 Jul 28.

PMID:
16051642
46.

Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer.

Coté ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG.

JAMA. 2005 Jun 22;293(24):3036-42.

PMID:
15972566
47.

Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.

Patel DA, Bock CH, Schwartz K, Wenzlaff AS, Demers RY, Severson RK.

Cancer Causes Control. 2005 Apr;16(3):263-73.

48.

Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.

Cote ML, Kardia SL, Wenzlaff AS, Land SJ, Schwartz AG.

Carcinogenesis. 2005 Apr;26(4):811-9. Epub 2005 Jan 20. Erratum in: Carcinogenesis. 2005 Jun;26(6):1158.

PMID:
15661806
49.

GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.

Wenzlaff AS, Cote ML, Bock CH, Land SJ, Schwartz AG.

Carcinogenesis. 2005 Feb;26(2):395-401. Epub 2004 Nov 4. Erratum in: Carcinogenesis. 2005 Apr;26(4):865.

PMID:
15528218
50.

NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.

Bock CH, Wenzlaff AS, Cote ML, Land SJ, Schwartz AG.

Carcinogenesis. 2005 Feb;26(2):381-6. Epub 2004 Oct 21.

PMID:
15498787

Supplemental Content

Loading ...
Support Center